WillScot Announces Investor Conference Schedule for September 2025

PHOENIX, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that it will participate in the following investor conference:

• D.A. Davidson Diversified Industrials & Services Conference
  Date: September 18, 2025
  Location: Nashville, Tennessee

A live webcast link will be posted on the company’s investor website. Portfolio managers and analysts who wish to request an in-person meeting should contact their sales representative at the sponsoring firm.

About WillScot

Listed on the Nasdaq stock exchange under the ticker symbol “WSC,” WillScot is the premier provider of highly innovative and turnkey space solutions in North America. The Company’s comprehensive range of products includes modular office complexes, mobile offices, classrooms, temporary restrooms, portable storage containers, protective buildings and climate-controlled units, and clearspan structures, as well as a curated selection of furnishings, appliances, and other supplementary services, ensuring turnkey solutions for its customers. Headquartered in Phoenix, Arizona, and operating from a network of approximately 260 branch locations and additional drop lots across the United States, Canada, and Mexico, WillScot’s business services are essential for diverse customer segments spanning all sectors of the economy.

Additional Information and Where to Find It
Additional information can be found on the company's website at www.willscot.com.

Contact Information

Investor inquiries:
Charlie Wohlhuter
[email protected]

Media inquiries:
Juliana Welling
[email protected]

You May Also Be Interested In

• OTraces Analysis of TEDDY Study Data Identifies Stage 3 Type 1 Diabetes Risk Up to Five Years Before Onset
• Tidal Wave Auto Spa Announces 18th Annual Charity Day on September 18, 2026
• Focus Health's Irving Health & Wellness Clinic Expands Its Medical Weight Loss Program, which includes Semaglutide and Tirzepatide, to include multiple new wellness treatments